Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Galen Limited
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
New OTC products and campaigns for the hay fever season from: GSK, Novartis, Dermapharm, Galenpharma, DHU and Thea Pharma.
- Contract Research, Toxicology Testing-CRO
- Generic Drugs
- Specialty Pharmaceuticals